- Home
- CMMB vs RVP Comparison
CMMB vs RVP Comparison
Compare CMMB & RVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMMB
- RVP
- Stock Information
- Founded
- CMMB 2004
- RVP 1994
- Country
- CMMB Israel
- RVP United States
- Employees
- CMMB N/A
- RVP N/A
- Industry
- CMMB Biotechnology: Pharmaceutical Preparations
- RVP Medical/Dental Instruments
- Sector
- CMMB Health Care
- RVP Health Care
- Exchange
- CMMB Nasdaq
- RVP Nasdaq
- Market Cap
- CMMB 23.0M
- RVP 22.8M
- IPO Year
- CMMB N/A
- RVP 2001
- Fundamental
- Price
- CMMB $1.32
- RVP $0.65
- Analyst Decision
- CMMB Strong Buy
- RVP
- Analyst Count
- CMMB 2
- RVP 0
- Target Price
- CMMB $8.50
- RVP N/A
- AVG Volume (30 Days)
- CMMB 109.4K
- RVP 65.2K
- Earning Date
- CMMB 05-15-2025
- RVP 05-15-2025
- Dividend Yield
- CMMB N/A
- RVP N/A
- EPS Growth
- CMMB N/A
- RVP N/A
- EPS
- CMMB N/A
- RVP N/A
- Revenue
- CMMB N/A
- RVP $33,745,343.00
- Revenue This Year
- CMMB N/A
- RVP N/A
- Revenue Next Year
- CMMB N/A
- RVP N/A
- P/E Ratio
- CMMB N/A
- RVP N/A
- Revenue Growth
- CMMB N/A
- RVP N/A
- 52 Week Low
- CMMB $0.78
- RVP $0.56
- 52 Week High
- CMMB $2.55
- RVP $1.22
- Technical
- Relative Strength Index (RSI)
- CMMB 50.69
- RVP 37.76
- Support Level
- CMMB $1.31
- RVP $0.70
- Resistance Level
- CMMB $1.44
- RVP $0.71
- Average True Range (ATR)
- CMMB 0.08
- RVP 0.05
- MACD
- CMMB 0.00
- RVP -0.01
- Stochastic Oscillator
- CMMB 54.55
- RVP 16.67
About CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101, treating rare fibrotic conditions.
About RVP Retractable Technologies Inc.
Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to the Company's other products.